MEDYSSEY Co.,Ltd (XKON:200580)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,960.00
-20.00 (-0.25%)
At close: Aug 1, 2025, 3:30 PM KST

Kronos Bio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2014FY 2013
Period Ending
Dec '14 Dec '13
Net Income
1,978891.91
Depreciation & Amortization
705.45784.37
Loss (Gain) From Sale of Assets
-11.36-66.04
Loss (Gain) From Sale of Investments
--18.5
Provision & Write-off of Bad Debts
174.54-1,071
Other Operating Activities
-81.7-264.94
Change in Accounts Receivable
-1,078380.16
Change in Inventory
-632.64-794.18
Change in Accounts Payable
-13.53-134.4
Change in Income Taxes
--266.37
Change in Other Net Operating Assets
105.03867.78
Operating Cash Flow
1,146308.53
Operating Cash Flow Growth
271.55%-
Capital Expenditures
-1,401-843.07
Sale of Property, Plant & Equipment
19.09269.7
Sale (Purchase) of Intangibles
-0.66-3.89
Sale (Purchase) of Real Estate
-195.3
Investment in Securities
-2,071-409.3
Other Investing Activities
-57.27-73
Investing Cash Flow
-3,539-859.02
Short-Term Debt Issued
4,0494,118
Long-Term Debt Issued
1,000500
Total Debt Issued
5,0494,618
Short-Term Debt Repaid
-4,851-3,306
Long-Term Debt Repaid
--519.38
Total Debt Repaid
-4,851-3,825
Net Debt Issued (Repaid)
198.09792.36
Issuance of Common Stock
3,521-
Other Financing Activities
-20
Financing Cash Flow
3,719812.36
Miscellaneous Cash Flow Adjustments
--0
Net Cash Flow
1,326261.87
Free Cash Flow
-254.34-534.55
Free Cash Flow Margin
-2.40%-7.52%
Free Cash Flow Per Share
-158.01-379.37
Levered Free Cash Flow
-1,023-
Unlevered Free Cash Flow
-965.72-
Change in Net Working Capital
1,554-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.